CoChat

Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality

Open access
ADHD Group of the Psychiatric Genomics Consortium, International Cannabis Consortium, Soler Artigas, María, Sánchez-Mora, Cristina, Rovira, Paula, Richarte, Vanesa, Garcia-Martínez, Iris, Pagerols, Mireia, Demontis, Ditte, Stringer, Sven, Vink, Jacqueline M., Børglum, Anders D., Neale, Benjamin M., Franke, Barbara, Faraone, Stephen V., Casas, Miguel, Ramos-Quiroga, Josep Antoni, Ribasés, Marta · 2020 · Molecular Psychiatry
Cited by 84

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Abstract

Attention-deficit/hyperactivity disorder (ADHD) is a severely impairing neurodevelopmental disorder with a prevalence of 5% in children and adolescents and of 2.5% in adults. Comorbid conditions in ADHD play a key role in symptom progression, disorder course and outcome. ADHD is associated with a significantly increased risk for substance use, abuse and dependence. ADHD and cannabis use are partly determined by genetic factors; the heritability of ADHD is estimated at 70–80% and of cannabis use initiation at 40–48%. In this study, we used summary statistics from the largest available meta-analyses of genome-wide association studies (GWAS) of ADHD ( n = 53,293) and lifetime cannabis use ( n = 32,330) to gain insights into the genetic overlap and causal relationship of these two traits. We estimated their genetic correlation to be r 2 = 0.29 ( P = 1.63 × 10 −5 ) and identified four new genome-wide significant loci in a cross-trait analysis: two in a single variant association analysis (rs145108385, P = 3.30 × 10 −8 and rs4259397, P = 4.52 × 10 −8 ) and two in a gene-based association analysis ( WDPCP , P = 9.67 × 10 −7 and ZNF251 , P = 1.62 × 10 −6 ). Using a two-sample Mendelian randomization approach we found support that ADHD is causal for lifetime cannabis use, with an odds ratio of 7.9 for cannabis use in individuals with ADHD in comparison to individuals without ADHD (95% CI (3.72, 15.51), P = 5.88 × 10 −5 ). These results substantiate the temporal relationship between ADHD and future cannabis use and reinforce the need to consider substance misuse in the context of ADHD in clinical interventions.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41380-018-0339-3

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 28 references

Cited by

See all 84

Metadata

Authors
ADHD Group of the Psychiatric Genomics Consortium, I. C. C., Soler Artigas, M., Sánchez-Mora, C., Rovira, P., Richarte, V., Garcia-Martínez, I., Pagerols, M., Demontis, D., Stringer, S., Vink, J. M., Børglum, A. D., Neale, B. M., Franke, B., Faraone, S. V., Casas, M., Ramos-Quiroga, J. A., & Ribasés, M.
Venue
Molecular Psychiatry
Published
2019-01-04
Volume
25
Issue
10
Pages
2493-2503
ISSN
  • 1359-4184 (ISSN-L)
  • 1476-5578
OpenAlex
W2908397286
Cited by
84
References
28
FWCI
7.91
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality. https://app.cochat.ai/papers/10.1038/s41380-018-0339-3
The paper
ADHD Group of the Psychiatric Genomics Consortium, I. C. C., Soler Artigas, M., Sánchez-Mora, C., Rovira, P., Richarte, V., Garcia-Martínez, I., Pagerols, M., Demontis, D., Stringer, S., Vink, J. M., Børglum, A. D., Neale, B. M., Franke, B., Faraone, S. V., Casas, M., Ramos-Quiroga, J. A., & Ribasés, M. (2020). Attention-deficit/hyperactivity disorder and lifetime cannabis use: genetic overlap and causality. Molecular Psychiatry. https://doi.org/10.1038/s41380-018-0339-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.